| Entry |
|
|---|
| Name |
(+)-(1S,2S)-Pseudoephedrine;
(+)-Pseudoephedrine;
Pseudoephedrine;
(1S,2S)-2-(Methylamino)-1-phenylpropan-1-ol
|
|---|
| Formula |
C10H15NO
|
|---|
| Exact mass |
165.1154
|
|---|
| Mol weight |
165.23
|
|---|
| Structure |
|
|---|
| Remark |
|
|---|
| Reaction |
|
|---|
| Pathway |
| map00996 | Biosynthesis of various alkaloids |
| map01063 | Biosynthesis of alkaloids derived from shikimate pathway |
|
|---|
| Enzyme |
|
|---|
| Brite |
Phytochemical compounds [BR:br08003]
Alkaloids
Alkaloids derived by amination reactions
Phenylalanine derived alkaloids
C02765 (+)-Pseudoephedrine
Secondary metabolites in pathway maps [br08011.html]
Biosynthetic pathways and modules of secondary metabolites
C02765
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R01 NASAL PREPARATIONS
R01B NASAL DECONGESTANTS FOR SYSTEMIC USE
R01BA Sympathomimetics
R01BA02 Pseudoephedrine
D08449 Pseudoephedrine (INN)
Risk category of Japanese OTC drugs [BR:br08312]
Designated second-class OTC drugs
Inorganic and organic chemicals
Pseudoephedrine
D08449 Pseudoephedrine (INN)
Second-class OTC drugs
Inorganic and organic chemicals
Pseudoephedrine
D08449 Pseudoephedrine (INN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01456 Adrenergic receptor agonist
DG01042 Pseudoephedrine
D08449 Pseudoephedrine
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
ADRA1
D08449 Pseudoephedrine (INN)
ADRA2
D08449 Pseudoephedrine (INN)
ADRB
D08449 Pseudoephedrine (INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 12
1 C8x C 24.0100 -21.1400
2 C8x C 24.0100 -22.5400
3 C8x C 25.2000 -23.2400
4 C8x C 26.3900 -22.5400
5 C8y C 26.3900 -21.1400
6 C8x C 25.2000 -20.4400
7 C1c C 27.6500 -20.4400
8 C1c C 28.8400 -21.1400
9 O1a O 27.6500 -19.0400
10 N1b N 30.0300 -20.4400
11 C1a C 28.8400 -22.5400
12 C1a C 31.2200 -21.1400
BOND 12
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 5 7 1
8 7 8 1
9 7 9 1 #Down
10 8 10 1
11 8 11 1 #Up
12 10 12 1
|
|---|
